Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.47%) $27.23
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Echtzeitaktualisierungen für Satsuma Pharmaceuticals [STSA]

Börse: NASDAQ Sektor: Healthcare Industrie: Biotechnology
Zuletzt aktualisiert7 Jun 2023 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 1.100

Live Chart Being Loaded With Signals

Commentary (7 Jun 2023 @ 22:00):
Profile picture for Satsuma Pharmaceuticals Inc

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device...

Stats
Tagesvolumen 1.83M
Durchschnittsvolumen 1.11M
Marktkapitalisierung 36.47M
EPS $0 ( 2024-03-26 )
Nächstes Ertragsdatum ( $0 ) 2024-05-09
Last Dividend $0.200 ( 2014-03-28 )
Next Dividend $0 ( N/A )
P/E -0.553
ATR14 $0.0510 (4.64%)
Insider Trading
Date Person Action Amount type
2023-06-08 Ra Capital Management, L.p. Sell 5 914 252 Common Stock
2023-06-08 Ra Capital Management, L.p. Sell 10 000 Stock Option (Right to Buy)
2023-06-08 Ra Capital Management, L.p. Sell 20 000 Stock Option (Right to Buy)
2023-06-08 Ra Capital Management, L.p. Sell 30 000 Stock Option (Right to Buy)
2023-06-06 O'neil Thomas P. Sell 13 877 Common Stock, $0.0001 par value
INSIDER POWER
54.69
Last 97 transactions
Buy: 62 291 817 | Sell: 17 994 879

Volumen Korrelation

Lang: 0.14 (neutral)
Kurz: 0.49 (neutral)
Signal:(60.819) Neutral

Satsuma Pharmaceuticals Korrelation

10 Am meisten positiv korreliert
NRBO0.956
DLTH0.937
NXTC0.934
TFFP0.933
TOI0.93
AGLE0.923
PRTK0.923
VIAV0.917
ONCS0.914
SGRP0.914
10 Am meisten negativ korreliert
AGFS-0.944
APEN-0.938
PRDO-0.932
NRIM-0.92
FANH-0.916
VLYPO-0.916
UFPT-0.916
MACK-0.914
TSBK-0.91
AMRB-0.906

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Satsuma Pharmaceuticals Korrelation - Währung/Rohstoff

The country flag 0.31
( neutral )
The country flag 0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.16
( neutral )
The country flag -0.25
( neutral )
The country flag 0.12
( neutral )

Satsuma Pharmaceuticals Finanzdaten

Annual 2022
Umsatz: $0
Bruttogewinn: $0 (0.00 %)
EPS: $-2.16
FY 2022
Umsatz: $0
Bruttogewinn: $0 (0.00 %)
EPS: $-2.16
FY 2021
Umsatz: $0.00
Bruttogewinn: $0.00 (0.00 %)
EPS: $-1.623
FY 2020
Umsatz: $0.00
Bruttogewinn: $0.00 (0.00 %)
EPS: $-2.73

Financial Reports:

No articles found.

Satsuma Pharmaceuticals Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

Satsuma Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.150 2012-12-19
Last Dividend $0.200 2014-03-28
Next Dividend $0 N/A
Payout Date 2014-04-15
Next Payout Date N/A
# dividends 7 --
Total Paid Out $1.500 --
Avg. Dividend % Per Year 0.00% --
Score 1.57 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-06-10)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
1.57
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-1.0861.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM1.3391.50010.0010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM7.440.80010.008.00[1 - 3]
quickRatioTTM7.090.80010.008.00[0.8 - 2.5]
cashRatioTTM3.351.50010.0010.00[0.2 - 2]
debtRatioTTM0.00267-1.5009.96-10.00[0 - 0.6]
interestCoverageTTM107.961.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.1132.00-0.371-0.742[0 - 30]
freeCashFlowPerShareTTM-1.1172.00-0.559-1.117[0 - 20]
debtEquityRatioTTM0.00308-1.5009.99-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-318.091.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.51

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.7731.000-0.1790[1 - 100]
returnOnEquityTTM1.3392.501.15210.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.1172.00-0.372-1.117[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.1132.00-0.371-0.742[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.005341.500-3.300[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-0.623

Satsuma Pharmaceuticals

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.